A group of experts at iniLabs, a company in Switzerland, has been working on lesson from biology. The aim, reportedly, is to reach an efficient camera that could see like the human retina.
The retina of the eye is really a powerful tool. It is being said that the same has the ability to sort through huge data. The retina works merely on a part of the power, which is needed in all by a computer and conventional digital camera.
The new camera has been dubbed the Dynamic Vision Sensor (DVS), which, according to the team, responds to a given scene's changes only. The same meant that the camera is working akin to the individual neurons there in the eyes.
It is the belief of the team that the approach wipes out large amounts of surplus data. Also, the same could prove highly helpful in a number of fields, comprising robotics, surveillance and microscopy.
Chief scientific officer, Tobi Delbruck, said that humans' eyes were nothing, but digital cameras, which are somewhat different.
"What we're talking about-the cameras sending information when something changes-is actually a very central theme to how the brain works, or at least how neuroscientists think it works", said computer scientist, Nabil Imam.
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recent statement sent out by social network...
Tech giant Apple’s online services were hit by a major...
Reuters has revealed in a recent report that Chinese...
In a livestream from the 2016 Computex event in Taiwan,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).